Literature DB >> 33525650

Identification of New Genes Involved in Germline Predisposition to Early-Onset Gastric Cancer.

Cristina Herrera-Pariente1, Roser Capó-García1, Marcos Díaz-Gay1,2, Sabela Carballal1, Jenifer Muñoz1, Joan Llach1, Ariadna Sánchez1, Laia Bonjoch1, Coral Arnau-Collell1, Yasmin Soares de Lima1, Mariano Golubicki3,4, Gerhard Jung1, Juan José Lozano5, Antoni Castells1, Francesc Balaguer1, Luis Bujanda6, Sergi Castellví-Bel1, Leticia Moreira1.   

Abstract

The genetic cause for several families with gastric cancer (GC) aggregation is unclear, with marked relevance in early-onset patients. We aimed to identify new candidate genes involved in GC germline predisposition. Whole-exome sequencing (WES) of germline samples was performed in 20 early-onset GC patients without previous germline mutation identified. WES was also performed in nine tumor samples to analyze the somatic profile using SigProfilerExtractor tool. Sequencing germline data were filtered to select those variants with plausible pathogenicity, rare frequency and previously involved in cancer. Then, a manual filtering was performed to prioritize genes according to current knowledge and function. These genetic variants were prevalidated with Integrative Genomics Viewer 2.8.2 (IGV). Subsequently, a further selection step was carried out according to function and information obtained from tumor samples. After IGV and selection step, 58 genetic variants in 52 different candidate genes were validated by Sanger sequencing. Among them, APC, FAT4, CTNND1 and TLR2 seem to be the most promising genes because of their role in hereditary cancer syndromes, tumor suppression, cell adhesion and Helicobacter pylori recognition, respectively. These encouraging results represent the open door to the identification of new genes involved in GC germline predisposition.

Entities:  

Keywords:  early-onset; gastric cancer; germline predisposition; next-generation sequencing; somatic profiling; whole-exome sequencing

Year:  2021        PMID: 33525650      PMCID: PMC7866206          DOI: 10.3390/ijms22031310

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  55 in total

1.  Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.

Authors:  Samantha Hansford; Pardeep Kaurah; Hector Li-Chang; Michelle Woo; Janine Senz; Hugo Pinheiro; Kasmintan A Schrader; David F Schaeffer; Karey Shumansky; George Zogopoulos; Teresa Almeida Santos; Isabel Claro; Joana Carvalho; Cydney Nielsen; Sarah Padilla; Amy Lum; Aline Talhouk; Katie Baker-Lange; Sue Richardson; Ivy Lewis; Noralane M Lindor; Erin Pennell; Andree MacMillan; Bridget Fernandez; Gisella Keller; Henry Lynch; Sohrab P Shah; Parry Guilford; Steven Gallinger; Giovanni Corso; Franco Roviello; Carlos Caldas; Carla Oliveira; Paul D P Pharoah; David G Huntsman
Journal:  JAMA Oncol       Date:  2015-04       Impact factor: 31.777

Review 2.  A review of capecitabine-based adjuvant therapy for gastric cancer in the Chinese population.

Authors:  Xiangdong Cheng; Yi Lu
Journal:  Future Oncol       Date:  2017-12-18       Impact factor: 3.404

3.  Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer.

Authors:  Ruta Sahasrabudhe; Paul Lott; Mabel Bohorquez; Ted Toal; Ana P Estrada; John J Suarez; Alejandro Brea-Fernández; José Cameselle-Teijeiro; Carla Pinto; Irma Ramos; Alejandra Mantilla; Rodrigo Prieto; Alejandro Corvalan; Enrique Norero; Carolina Alvarez; Teresa Tapia; Pilar Carvallo; Luz M Gonzalez; Alicia Cock-Rada; Angela Solano; Florencia Neffa; Adriana Della Valle; Chris Yau; Gabriela Soares; Alexander Borowsky; Nan Hu; Li-Ji He; Xiao-You Han; Philip R Taylor; Alisa M Goldstein; Javier Torres; Magdalena Echeverry; Clara Ruiz-Ponte; Manuel R Teixeira; Luis G Carvajal-Carmona
Journal:  Gastroenterology       Date:  2016-12-23       Impact factor: 22.682

4.  Catenin family genes are not commonly mutated in hereditary diffuse gastric cancer.

Authors:  Johanna M Schuetz; Stephen Leach; Pardeep Kaurah; Jennifer Jeyes; Yaron Butterfield; David Huntsman; Angela R Brooks-Wilson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-15       Impact factor: 4.254

5.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

6.  Low FAT4 expression is associated with a poor prognosis in gastric cancer patients.

Authors:  Xiaoting Jiang; Zhengchuang Liu; Yingjie Xia; Jungang Luo; Ji Xu; Xujun He; Houquan Tao
Journal:  Oncotarget       Date:  2017-12-26

7.  Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.

Authors:  Eleanor Fewings; Alexey Larionov; James Redman; Mae A Goldgraben; James Scarth; Susan Richardson; Carole Brewer; Rosemarie Davidson; Ian Ellis; D Gareth Evans; Dorothy Halliday; Louise Izatt; Peter Marks; Vivienne McConnell; Louis Verbist; Rebecca Mayes; Graeme R Clark; James Hadfield; Suet-Feung Chin; Manuel R Teixeira; Olivier T Giger; Richard Hardwick; Massimiliano di Pietro; Maria O'Donovan; Paul Pharoah; Carlos Caldas; Rebecca C Fitzgerald; Marc Tischkowitz
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-04-27

Review 8.  Risk Factors for Gastric Cancer: A Systematic Review

Authors:  Ali Reza Yusefi; Kamran Bagheri Lankarani; Peivand Bastani; Zahra Kavosi
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27

9.  The role of TLR2, TLR4 and CD14 genetic polymorphisms in gastric carcinogenesis: a case-control study and meta-analysis.

Authors:  Natalia Castaño-Rodríguez; Nadeem O Kaakoush; Khean-Lee Goh; Kwong Ming Fock; Hazel M Mitchell
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

Review 10.  History and progression of Fat cadherins in health and disease.

Authors:  Xiaofeng Zhang; Jinghua Liu; Xiao Liang; Jiang Chen; Junjie Hong; Libo Li; Qiang He; Xiujun Cai
Journal:  Onco Targets Ther       Date:  2016-12-01       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.